Small Molecules
21 March 2014
CHMP Recommends Empagliflozin for Approval to Reduce Blood Sugar Levels in Adults with Type 2 Diabetes in Europe21 March 2014
Janssen Investigational Treatment for Schizophrenia Shows Positive Efficacy, Delays Relapse21 March 2014
Novartis reports data at EBCC-9 for secondary survival endpoint of Afinitor trial in HR+/HER2- advanced breast cancer19 March 2014
BNC105 Phase II Renal Cancer Trial Results18 March 2014
Ironwood Pharmaceuticals Initiates Phase II Clinical Study of IW-3718 in Refractory Gastroesophageal Reflux Disease18 March 2014
Pharma Two B Commences Phase IIb Study of Fixed Dose Combination Therapy “P2B001” for Parkinson’s Disease18 March 2014
Alcobra Announces Enrollment of First Patient in Phase 3 Clinical Trial for MDX in Adult ADHD17 March 2014
Pierre Fabre Obtains FDA Approval to Market HemangeolTM for the Treatment of Infantile Hemangioma17 March 2014
Ocular Therapeutix Begins Phase 3 Clinical Trial for its Sustained Release Dexamethasone16 March 2014
Two New Studies Support Use of EXPAREL for Postsurgical Pain Management Following Total Joint ReplacementNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports